the benefits of glp-1 drugs beyond obesity are changing more than number on the scale. From diabetes and to heart, kidney, and metabolic health — this story is getting bigger fast. ❤️ Swipe to learn Beyond the anti-obesity benefits of

Of note, more than 50% of participants in the tirzepatide 10 and 15 mg groups experienced weight reductions of over 20%

The muscle loss conversation around GLP-1sand now triple agonists like retatrutideneeds more clinical context

95% CI [0.680.99])

As the confounding structure for the head-to-head comparison of tirzepatide versus semaglutide was expected to be more similar to the tirzepatide versus dulaglutide benchmarking study, we proceeded with the prespecified analysis plan that included death in the primary composite MACE outcome

Up to now, most explanations have centered on the brain, lower dopamine signaling, reduced craving, less reactivity to alcohol cues in reward regions like the ventral tegmental area and nucleus accumbens

The polling industrys professional body, the Canadian Research Insights Council, says online surveys cannot be assigned a margin of error because they do not randomly sample the population.